Ann Surg Oncol3 Nov 2023
This study navigates the ongoing debate over whether neoadjuvant radiation should be combined with chemotherapy in the treatment of resectable gastric cancer. While awaiting results from specific clinical trials, experts discuss the pros and cons. Neoadjuvant radiation may be better tolerated and improve pathologic response,…
HPB & Spleen3 Nov 2023
This study delves into pancreatic cancer outcomes in the disaggregated Asian American, Native Hawaiian, and Pacific Islander (AANHPI) population, which is often underrepresented in scientific research. Analyzing data from 296,448 patients, it reveals that AANHPI patients, as a whole, exhibited better median survival than Caucasians…
Ann Surg Oncol3 Nov 2023
Researchers examined the role of mesenteric lymph nodes (MLNs) in digestive resection for advanced ovarian cancer (OC) with peritoneal metastases. Out of 159 patients, 77 underwent digestive resection, with 61.1% having MLNs examined, and 56.8% showed involvement. Surprisingly, MLN status didn't significantly impact overall survival…
Ann Surg Oncol3 Nov 2023
When dealing with recurring mucinous appendiceal adenocarcinoma, undergoing repeat cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can be a game-changer. This study from MD Anderson Cancer Center reveals that patients who opt for repeat CRS/HIPEC enjoy similar recurrence-free survival compared to those initially treated,…
BMC Surg3 Nov 2023
This study explored how sarcopenia, muscle loss often seen in cancer patients, impacts outcomes for esophageal adenocarcinoma patients undergoing neoadjuvant therapy. Among 71 patients, those who developed sarcopenia before surgery had significantly worse overall survival compared to those who were sarcopenic at diagnosis or experienced…
Dis Colon Rectum3 Nov 2023
In this study, researchers delved into surgical outcomes for inflammatory bowel disease patients based on their sex. Analyzing data from over 3,000 patients, they discovered that women had lower odds of serious adverse events compared to men. This difference was particularly notable in patients with…
Surg Endosc3 Nov 2023
This groundbreaking study introduces Imaging Photoplethysmography (IPPg) as a new method for quantitatively evaluating organ perfusion during laparoscopic surgeries. In clinical settings, researchers successfully used a laparoscope connected to a digital monochrome camera, along with green light illumination, to assess organ perfusion in cancer patients.…
Am J Surg3 Nov 2023
This groundbreaking study analyzed the outcomes of robotic hepatectomy for five major malignant liver diseases. Among the 210 patients who underwent this procedure, including cases like colorectal liver metastases and hepatocellular carcinoma, the results were promising. A favorable 5-year overall survival benefit was observed across…
Gastrointest Endosc2 Nov 2023
Researchers conducted a study at Asan Medical Center to assess the feasibility, effectiveness, and safety of EUS-guided radiofrequency ablation (EUS-RFA) for treating left adrenal tumors. The results were promising, with a 100% technical success rate in performing EUS-RFA. Most patients (73%) achieved a complete response…
Gastrointest Endosc2 Nov 2023
In high-risk surgical patients with acute cholecystitis, a systematic review and meta-analysis compared two alternative treatments: endoscopic ultrasound-guided gallbladder drainage using lumen-apposing metal stents (EUS-GBD-LAMS) and percutaneous cholecystostomy (PTGBD). The study found that while the two groups had similar early adverse events, EUS-GBD-LAMS was associated…